{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:07:23Z","timestamp":1791058043230,"version":"4.1.0"},"reference-count":41,"publisher":"American Diabetes Association","issue":"4","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"abstract":"<jats:p>Proinflammatory cytokines including interleukin (IL)-1 and IL-6 exert pleiotropic effects on the neuro-immuno-endocrine system. Previously, we showed that IL-1 receptor antagonist\u2013deficient (IL-1Ra\u2212\/\u2212) mice show a lean phenotype due to an abnormal lipid metabolism. On the contrary, it was reported that IL-6\u2212\/\u2212 mice exhibit obesity after 6 months of age. This study sought to assess the roles of IL-1 and IL-6 in body weight homeostasis. We generated mice deficient in IL-6 and IL-1Ra (IL-6\u2212\/\u2212 IL-1Ra\u2212\/\u2212) and IL-6, IL-1\u03b1, and IL-1\u03b2 (IL-6\u2212\/\u2212 IL-1\u2212\/\u2212). IL-6\u2212\/\u2212 IL-1Ra\u2212\/\u2212 mice exhibited a lean phenotype, similar to IL-1Ra\u2212\/\u2212 mice. On the other hand, IL-6\u2212\/\u2212 IL-1\u2212\/\u2212 mice became obese as early as 10 weeks of age, while IL-1\u2212\/\u2212 mice and IL-6\u2212\/\u2212 mice were normal at this age. The daily food intake was significantly higher in IL-6\u2212\/\u2212 IL-1\u2212\/\u2212 mice than in IL-6\u2212\/\u2212 IL-1+\/\u2212 mice, while energy expenditure was comparable in these two strains. Acute anorexia induced by peripheral administration of IL-1 was significantly suppressed in IL-6\u2212\/\u2212 IL-1\u2212\/\u2212 mice, but not in IL-1\u2212\/\u2212 mice or IL-6\u2212\/\u2212 mice compared with wild-type mice. These results indicate that IL-1 and IL-6 are both involved in the regulation of body fat in a redundant manner in young mice.<\/jats:p>","DOI":"10.2337\/diabetes.55.04.06.db05-1250","type":"journal-article","created":{"date-parts":[[2006,5,8]],"date-time":"2006-05-08T22:24:58Z","timestamp":1147127098000},"page":"971-977","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":71,"title":["Combined Interleukin-6 and Interleukin-1 Deficiency Causes Obesity in Young Mice"],"prefix":"10.2337","volume":"55","author":[{"given":"Dai","family":"Chida","sequence":"first","affiliation":[{"name":"Division of Cell Biology, Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Osaka","sequence":"additional","affiliation":[{"name":"National Institute of Health and Nutrition, Shinjuku, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okito","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Division of Cell Biology, Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Iwakura","sequence":"additional","affiliation":[{"name":"Division of Cell Biology, Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031217163920600_R1","doi-asserted-by":"crossref","unstructured":"Tocci MJ, Schmidt JA: Interleukin-1: structure and function. In Cytokines in Health and Disease. 2nd ed. Remick DG, Friedland JS, Eds. New York, Marcel Dekker,1997, p.1\u201327","DOI":"10.1016\/S0083-6729(08)60703-7"},{"key":"2022031217163920600_R2","doi-asserted-by":"crossref","unstructured":"Laye S, Gheusi G, Cremona S, Combe C, Kelley K, Dantzer R, Parnet P: Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am J Physiol Regul Integr Comp Physiol\u2008279:R93\u2013R98,2000","DOI":"10.1152\/ajpregu.2000.279.1.R93"},{"key":"2022031217163920600_R3","doi-asserted-by":"crossref","unstructured":"Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature\u2008395:763\u2013770,1998","DOI":"10.1038\/27376"},{"key":"2022031217163920600_R4","doi-asserted-by":"crossref","unstructured":"Luheshi GN, Gardner JD, Rushforth DA, Loudon AS, Rothwell NJ: Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci U S A\u200896:7047\u20137052,1999","DOI":"10.1073\/pnas.96.12.7047"},{"key":"2022031217163920600_R5","doi-asserted-by":"crossref","unstructured":"Meier CA, Bobbioni E, Gabay C, Assimacopoulos-Jeannet F, Golay A, Dayer JM: IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?J Clin Endocrinol Metab\u200887:1184\u20131188,2002","DOI":"10.1210\/jcem.87.3.8351"},{"key":"2022031217163920600_R6","doi-asserted-by":"crossref","unstructured":"Juge-Aubry CE, Somm E, Giusti V, Pernin A, Chicheportiche R, Verdumo C, Rohner-Jeanrenaud F, Burger D, Dayer JM, Meier CA: Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes\u200852:1104\u20131110,2003","DOI":"10.2337\/diabetes.52.5.1104"},{"key":"2022031217163920600_R7","doi-asserted-by":"crossref","unstructured":"Matsuki T, Horai R, Sudo K, Iwakura Y: IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med\u2008198:877\u2013888,2003","DOI":"10.1084\/jem.20030299"},{"key":"2022031217163920600_R8","doi-asserted-by":"crossref","unstructured":"Garcia M, Werstedt I, Berndtsson A, Enge M, Ahren B, Horn M, Ohlsson C, Wallenius V, Jansson JO: Mature onset obesity in interleukin-1 receptor I (IL-1RI) knockout mice. In Keystone Symposia Obesity: Molecular Physiology and Genetics of the Control of Body Weight. Keystone, CO, Keystone Symposia,2005, p.130","DOI":"10.2337\/db05-1304"},{"key":"2022031217163920600_R9","doi-asserted-by":"crossref","unstructured":"Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab\u200882:4196\u20134200,1997","DOI":"10.1210\/jc.82.12.4196"},{"key":"2022031217163920600_R10","doi-asserted-by":"crossref","unstructured":"Fried SK, Bunkin DA, Greenberg AS: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab\u200883:847\u2013850,1998","DOI":"10.1210\/jc.83.3.847"},{"key":"2022031217163920600_R11","doi-asserted-by":"crossref","unstructured":"Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP: Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab\u200885:1151\u20131158,2000","DOI":"10.1210\/jcem.85.3.6484"},{"key":"2022031217163920600_R12","doi-asserted-by":"crossref","unstructured":"Schobitz B, de Kloet ER, Sutanto W, Holsboer F: Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci\u20085:1426\u20131435,1993","DOI":"10.1111\/j.1460-9568.1993.tb00210.x"},{"key":"2022031217163920600_R13","doi-asserted-by":"crossref","unstructured":"Shizuya K, Komori T, Fujiwara R, Miyahara S, Ohmori M, Nomura J, Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP: The expressions of mRNAs for interleukin-6 (IL-6) and the IL-6 receptor (IL-6R) in the rat hypothalamus and midbrain during restraint stress. Life Sci\u200862:2315\u20132320,1998","DOI":"10.1016\/S0024-3205(98)00212-4"},{"key":"2022031217163920600_R14","doi-asserted-by":"crossref","unstructured":"Aschner M, Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP: Immune and inflammatory responses in the CNS: modulation by astrocytes. Toxicol Lett\u2008103:283\u2013287,1998","DOI":"10.1016\/S0378-4274(98)00324-5"},{"key":"2022031217163920600_R15","doi-asserted-by":"crossref","unstructured":"Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO: Interleukin-6-deficient mice develop mature-onset obesity. Nat Med\u20088:75\u201379,2002","DOI":"10.1038\/nm0102-75"},{"key":"2022031217163920600_R16","doi-asserted-by":"crossref","unstructured":"Wallenius K, Wallenius V, Sunter D, Dickson SL, Jansson JO: Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun\u2008293:560\u2013565,2002","DOI":"10.1016\/S0006-291X(02)00230-9"},{"key":"2022031217163920600_R17","doi-asserted-by":"crossref","unstructured":"Faldt J, Wernstedt I, Fitzgerald SM, Wallenius K, Bergstrom G, Jansson JO: Reduced exercise endurance in interleukin-6-deficient mice. Endocrinology\u2008145:2680\u20132686,2004","DOI":"10.1210\/en.2003-1319"},{"key":"2022031217163920600_R18","doi-asserted-by":"crossref","unstructured":"Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, Nishihara M, Takahashi M, Iwakura Y: Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha\/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med\u2008187:1463\u20131475,1998","DOI":"10.1084\/jem.187.9.1463"},{"key":"2022031217163920600_R19","doi-asserted-by":"crossref","unstructured":"Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G: Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature\u2008368:339\u2013342,1994","DOI":"10.1038\/368339a0"},{"key":"2022031217163920600_R20","doi-asserted-by":"crossref","unstructured":"Kagiwada K, Chida D, Sakatani T, Asano M, Nambu A, Kakuta S, Iwakura Y: Interleukin (IL)-6, but not IL-1, induction in the brain downstream of cyclooxygenase-2 is essential for the induction of febrile response against peripheral IL-1alpha. Endocrinology\u2008145:5044\u20135048,2004","DOI":"10.1210\/en.2004-0054"},{"key":"2022031217163920600_R21","doi-asserted-by":"crossref","unstructured":"Spiegelman BM, Flier JS: Obesity and the regulation of energy balance. Cell\u2008104:531\u2013543,2001","DOI":"10.1016\/S0092-8674(01)00240-9"},{"key":"2022031217163920600_R22","doi-asserted-by":"crossref","unstructured":"Dinarello CA: Biologic basis for interleukin-1 in disease. Blood\u200887:2095\u20132147,1996","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095"},{"key":"2022031217163920600_R23","doi-asserted-by":"crossref","unstructured":"Dinarello CA: Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol\u200816:457\u2013499,1998","DOI":"10.3109\/08830189809043005"},{"key":"2022031217163920600_R24","doi-asserted-by":"crossref","unstructured":"Plata-Salaman CR: Cytokines and feeding. Int J Obes Relat Metab Disord\u200825:S48\u201352,2001","DOI":"10.1038\/sj.ijo.0801911"},{"key":"2022031217163920600_R25","doi-asserted-by":"crossref","unstructured":"Chai Z, Gatti S, Toniatti C, Poli V, Bartfai T: Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice. J Exp Med\u2008183:311\u2013316,1996","DOI":"10.1084\/jem.183.1.311"},{"key":"2022031217163920600_R26","doi-asserted-by":"crossref","unstructured":"Chida D, Imaki T, Suda T, Iwakura Y: Involvement of corticotropin-releasing hormone- and interleukin (IL)-6-dependent proopiomelanocortin induction in the anterior pituitary during hypothalamic-pituitary-adrenal axis activation by IL-1{alpha}. Endocrinology\u2008146:5496\u20135502,2005","DOI":"10.1210\/en.2005-0409"},{"key":"2022031217163920600_R27","doi-asserted-by":"crossref","unstructured":"Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med\u20081:1155\u20131161,1995","DOI":"10.1038\/nm1195-1155"},{"key":"2022031217163920600_R28","doi-asserted-by":"crossref","unstructured":"Lawrence CB, Rothwell NJ: Anorexic but not pyrogenic actions of interleukin-1 are modulated by central melanocortin-3\/4 receptors in the rat. J Neuroendocrinol\u200813:490\u2013495,2001","DOI":"10.1046\/j.1365-2826.2001.00660.x"},{"key":"2022031217163920600_R29","doi-asserted-by":"crossref","unstructured":"Gayle D, Ilyin SE, Plata-Salaman CR, Sonti G: Central nervous system IL-1 beta system and neuropeptide Y mRNAs during IL-1 beta-induced anorexia in rats neuropeptide Y blocks and reverses interleukin-1 beta-induced anorexia in rats. Brain Res Bull\u200844:311\u2013317,1997","DOI":"10.1016\/S0361-9230(97)00159-7"},{"key":"2022031217163920600_R30","doi-asserted-by":"crossref","unstructured":"Sonti G, Ilyin SE, Plata-Salaman CR: Neuropeptide Y blocks and reverses interleukin-1 beta-induced anorexia in rats. Peptides\u200817:517\u2013520,1996","DOI":"10.1016\/0196-9781(96)00016-2"},{"key":"2022031217163920600_R31","doi-asserted-by":"crossref","unstructured":"Senn JJ, Klover PJ, Nowak IA, Mooney RA: Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes\u200851:3391\u20133399,2002","DOI":"10.2337\/diabetes.51.12.3391"},{"key":"2022031217163920600_R32","doi-asserted-by":"crossref","unstructured":"Kim HJ, Higashimori T, Park SY, Choi H, Dong J, Kim YJ, Noh HL, Cho YR, Cline G, Kim YB, Kim JK, Klover PJ, Zimmers TA, Koniaris LG, Mooney RA: Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes\u200853:1060\u20131067,2004","DOI":"10.2337\/diabetes.53.4.1060"},{"key":"2022031217163920600_R33","doi-asserted-by":"crossref","unstructured":"Rotter V, Nagaev I, Smith U: Interleukin-6 (IL-6) induces insulin resistance in 3T3\u2013L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem\u2008278:45777\u201345784,2003","DOI":"10.1074\/jbc.M301977200"},{"key":"2022031217163920600_R34","doi-asserted-by":"crossref","unstructured":"van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA, Pedersen BK: Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab\u200888:3005\u20133010,2003","DOI":"10.1210\/jc.2002-021687"},{"key":"2022031217163920600_R35","doi-asserted-by":"crossref","unstructured":"Kanemaki T, Kitade H, Kaibori M, Sakitani K, Hiramatsu Y, Kamiyama Y, Ito S, Okumura T: Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology\u200827:1296\u20131303,1998","DOI":"10.1002\/hep.510270515"},{"key":"2022031217163920600_R36","doi-asserted-by":"crossref","unstructured":"Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY: Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest\u2008110:851\u2013860,2002","DOI":"10.1172\/JCI200215318"},{"key":"2022031217163920600_R37","doi-asserted-by":"crossref","unstructured":"Rothwell NJ, Hopkins SJ: Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci\u200818:130\u2013136,1995","DOI":"10.1016\/0166-2236(95)93890-A"},{"key":"2022031217163920600_R38","doi-asserted-by":"crossref","unstructured":"Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest\u2008112:1796\u20131808,2003","DOI":"10.1172\/JCI200319246"},{"key":"2022031217163920600_R39","doi-asserted-by":"crossref","unstructured":"Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest\u2008112:1821\u20131830,2003","DOI":"10.1172\/JCI200319451"},{"key":"2022031217163920600_R40","doi-asserted-by":"crossref","unstructured":"Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE: Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med\u200811:183\u2013190,2005","DOI":"10.1038\/nm1166"},{"key":"2022031217163920600_R41","doi-asserted-by":"crossref","unstructured":"Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M: IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med\u200811:191\u2013198,2005","DOI":"10.1038\/nm1185"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/55\/4\/971\/383527\/zdb00406000971.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/55\/4\/971\/383527\/zdb00406000971.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:29:02Z","timestamp":1667406542000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/55\/4\/971\/25564\/Combined-Interleukin-6-and-Interleukin-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,1]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.55.04.06.db05-1250","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,1]]}}}